Works by Berger, Tamar


Results: 41
    1

    Suburban Realities: The Israeli Case.

    Published in:
    CLCWeb: Comparative Literature & Culture: A Web Journal, 2019, v. 21, n. 2, p. 1, doi. 10.7771/1481-4374.3570
    By:
    • Berger, Tamar
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 14, p. 3384, doi. 10.1080/10428194.2021.1966782
    By:
    • Levy, Ilana;
    • Lavi, Avital;
    • Zimran, Eran;
    • Grisariu, Sigal;
    • Aumann, Shlomzion;
    • Itchaki, Gilad;
    • Berger, Tamar;
    • Raanani, Pia;
    • Harel, Reut;
    • Aviv, Ariel;
    • Lavi, Noa;
    • Zuckerman, Tsila;
    • Shvidel, Lev;
    • Jarchowsky, Osnat;
    • Ellis, Martin;
    • Herzog Tzarfati, Katrin;
    • Koren-Michowitz, Maya;
    • Sherf, Yehonatan;
    • Levi, Itai;
    • Sofer, Orit
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.

    Published in:
    British Journal of Haematology, 2023, v. 200, n. 1, p. 45, doi. 10.1111/bjh.18479
    By:
    • Shragai, Tamir;
    • Magen, Hila;
    • Lavi, Noa;
    • Gatt, Moshe;
    • Trestman, Svetlana;
    • Zektser, Miri;
    • Ganzel, Chezi;
    • Jarchowsky, Osnat;
    • Berger, Tamar;
    • Tadmor, Tamar;
    • Leiba, Merav;
    • Hertzog‐Tzarfaty, Katrin;
    • Horowitz, Netanel;
    • Shapira, Michael;
    • Varssano, David;
    • Berger, Yoav;
    • Frenkel, Shahar;
    • Krauthammer, Mark;
    • Avivi, Irit;
    • Luttwak, Efrat
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Midostaurin in Combination with Intensive Chemotherapy is Safe and Associated with Improved Remission Rates and Higher Transplantation Rates in First Remission-A Multi-Center Historical Control Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S208, doi. 10.1016/j.clml.2019.07.072
    By:
    • Berger, Tamar;
    • Uri, Rozovski;
    • Moshe, Yakir;
    • Yaari, Shilo;
    • Frisch, Avraham;
    • Hellmann, Ilana;
    • Apel, Arie;
    • Aviram, Adina;
    • Koren-Michowitz, Maya;
    • Yeshurun, Moshe;
    • Ram, Ron;
    • Raanani, Pia;
    • Ofran, Yishai;
    • Wolach, Ofir
    Publication type:
    Article
    39
    40
    41

    Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3‐ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 1, p. 64, doi. 10.1111/ejh.13518
    By:
    • Ofran, Yishai;
    • Leiba, Ronit;
    • Frisch, Avraham;
    • Horesh, Nurit;
    • Henig, Israel;
    • Yehudai‐Ofir, Dana;
    • Moshe, Yakir;
    • Neaman, Miriam;
    • Ganzel, Chezi;
    • Gal‐Rabinovich, Kinneret;
    • Hellmann, Ilana;
    • Weinstein, Vladimir;
    • Berger, Tamar;
    • Wolach, Ofir
    Publication type:
    Article